Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation
Elizabeth F. Krakow(Fred Hutch Cancer Center), Eli Estey(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mary E.D. Flowers(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nayak L. Polissar(The Mount), Tess Perez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Julia M. Nathe(Indiana University School of Medicine), Ljubomir Miljacic(The Mount), Anna B. Halpern(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ali R Ahmed(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Roland B. Walter(Rafael Advanced Defense Systems (Israel))
Cited by 22
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k